Clamp application
- The key consideration is the site of clamp application, with more proximal clamping having a more profound haemodynamic effect
- One the clamp is applied, there is a large increase in SVR
- This massively increases afterload
- There is an increase in arterial pressure proximal to the clamp (MAP ↑50%)
- Filling pressure (↑40%) and ejection fraction (↓40%) are also effected
- In order to maintain cardiac output, there is:
- Sympathetic stimulation, increasing heart rate and contractility
- Increased preload from central veins, increasing contractility via Frank-Starling mechanism
- There is a perfect storm for myocardial ischaemia, with:
- Reduced coronary perfusion pressure (as CPP = AoDBP - LVEDP, the latter of which is elevated) and therefore myocardial oxygen supply
- Increased myocardial oxygen demand on account of greater contractility
- There is consequent myocardial RMWA in 33% (supra-renal clamp) to >90% (supra-coeliac clamp) of patients, even if normal hearts pre-operatively
- Heart failure may occur too
- The therapeutic aim of the anaesthetist is to reduce afterload by decreasing SVR through vasodilation:
- Deepening depth of anaesthesia
- Use of opioids
- Direct vasodilators such as GTN or sodium nitroprusside
- Vasodilation may facilitate fluid loading in anticipation of post-clamp hypotension
- Vasodilators mayn't, however, improve cardiac output and can cause blood re-distribution, which may affect tissue perfusion
Clamp release
- Release of the clamp causes a 70 - 80% decrease in SVR
- This effect is compounded by:
- Blood sequestration in the lower body, particularly the splanchnic circulation
- Washout of anaerobic metabolites (H+, K+, adenosine, ADP, purines, hypoxanthine, xanthine oxidase) causes:
- Ischaemia-reperfusion injury
- Metabolic lactic acidosis leading to direct myocardial suppression
- Peripheral vasodilation
- These changes reduce LVEDV (preload) and coronary blood flow
- The net effect of reduced SVR, reduced preload and myocardial flailing is hypotension
- Methods to minimise the haemodynamic instability associated with clamp release are:
- Optimising intravascular volume in the pre-release phase
- Administration in the post-release phase is less effective
- Hyperventilation to minimise acidosis caused by CO2 returning from the lower limbs
- Gradual release of the cross-clamp by the surgeons
- Use of vasoactive drugs
- These drugs tend to be less effective following cross-clamp release as anaerobic metabolites reduce the sensitivity of adrenergic receptors in areas distal to the clamp
- Vasoconstrictors may lower cardiac output and divert blood away from the central compartment
- Ensure normal clotting by avoiding hypothermia and acidosis
- Overall, management of cross-clamp application and release requires excellent surgeon-anaesthetist communication to anticipate and mitigate the physiological effect